FRM
SCLN

Fox Run Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Fox Run Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-28,700
Closed -$321K – 1009
2017
Q3 		$321K Buy
+28,700
New +$321K 0.09% 460
2016
Q4 		– Sell
-22,400
Closed -$230K – 779
2016
Q3 		$230K Buy
22,400
+8,600
+62% +$88.3K 0.14% 362
2016
Q2 		$180K Buy
+13,800
New +$180K 0.09% 458